0001437749-24-018775.txt : 20240530
0001437749-24-018775.hdr.sgml : 20240530
20240530181053
ACCESSION NUMBER: 0001437749-24-018775
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240528
FILED AS OF DATE: 20240530
DATE AS OF CHANGE: 20240530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robinson Chandler
CENTRAL INDEX KEY: 0001727334
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 241007001
MAIL ADDRESS:
STREET 1: C/O SKOKIE BLVD., SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-05-28
0001645469
Monopar Therapeutics
MNPR
0001727334
Robinson Chandler
1000 SKOKIE BLVD SUITE 350
WILMETTE
IL
60091
1
1
Chief Executive Officer
0
Common Stock
2024-05-28
4
X
0
84000
0.001
A
250130.80
D
Common Stock
4111272.88
I
See Footnote
Common Stock
166667
I
See Footnote
Stock Options
0.001
2024-05-28
4
X
0
84000
0
D
2026-04-03
Common Stock
84000
0
D
This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
This is based upon the 4,111,272.88 shares of Monopar Common Stock that Tactic Pharma LLC indirectly controls through TacticGem LLC. As a manager of Tactic Pharma LLC, Dr. Robinson may be deemed to share voting and dispositive power over these 4,111,272.88 shares. Dr. Robinson disclaims beneficial ownership of the 4,111,272.88 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
This is based upon the 166,667 shares of Monopar Common Stock that Tactic Pharma LLC directly owns. As a manager of Tactic Pharma LLC, Dr. Robinson may be deemed to share voting and dispositive power over these 166,667 shares. Dr. Robinson disclaims beneficial ownership of the 166,667 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein
Reflects options to purchase up to 84,000 shares of common stock granted to Dr. Robinson on April 4, 2016 for his services as a director and officer of Monopar Therapeutics. The options vested 50% upon grant date, 25% upon the 6-month anniversary of grant date, and 25% upon the 1-year anniversary of grant date.
/s/ Kim R Tsuchimoto, Attorney-in-fact
2024-05-30